Ultragenyx Pharmaceutical Inc (RARE)

95.11 -2.39  -2.45% NASDAQ Sep 24, 16:00 95.29 +0.18  +0.19% Pre-Market: 20:00 USD
View Full Chart
Price Chart
View All RARE News

News

View All Events

Events

Date Type Description
10/27/2021 Earnings Results Q3 2021 Earnings Results
10/27/2021 17:00 EST Earnings Calls Q3 2021 Earnings Call
08/02/2021 Earnings Results Q2 2021 Earnings Results
08/02/2021 17:00 EST Earnings Calls Q2 2021 Earnings Call
06/24/2021 11:00 EST AGM 2020 Annual General Meeting
05/04/2021 Earnings Results Q1 2021 Earnings Results
05/04/2021 17:00 EST Earnings Calls Q1 2021 Earnings Call
02/11/2021 Earnings Results Q4 2020 Earnings Results
02/11/2021 17:00 EST Earnings Calls Q4 2020 Earnings Call
10/27/2020 Earnings Results Q3 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Ultragenyx Pharmaceutical Inc is a US-based biopharmaceutical company. It identifies, acquires, develops, and commercialize novel products for the treatment of serious rare and ultra-rare diseases, with the focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
  • URL: https://www.ultragenyx.com
  • Investor Relations URL: https://ir.ultragenyx.com/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Oct. 27, 2021
  • Last Earnings Release: Aug. 02, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
FBT First Trust NYSE Arca Biotech ETF 3.60%
MFMS MFAM Small-Cap Growth ETF 3.49%
GNOM Global X Genomics & Biotechnology ETF 3.33%
KAUBX Federated Hermes Kaufmann B 1.93%
FKBSX Federated Hermes Kaufmann Small Cap B 1.35%
SGFCX Sparrow Growth C 1.23%
TDB875 TD Health Sciences Fund - O 1.08%
BTEC Principal Healthcare Innovators ETF 0.91%
TDB925 TD U.S. Small-Cap Equity Fund - O 0.88%
NSGRX Northern Small Cap Core I 0.22%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.